Chongqing Lummy Pharmaceutical Co.,Ltd. Posted 63.1 Million Yuan Net Loss in First Half of 2023

Chongqing Lummy Pharmaceutical Co.,Ltd. (重庆莱美药业股份有限公司) (300006.SZ) reported a net loss of 63.1 million yuan in the first half of 2023, widening 15.1% year-on-year.

Meanwhile, the company posted 453.9 million yuan in revenue, up 11.7% year-on-year.

At the end of the reporting period, it had 2.9 billion yuan in total assets and 816.5 million yuan in total liabilities, with a liability-to-asset ratio of 28%.